CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Top Player Positioning
3.4.Porter's five forces analysis
3.5.COVID-19 impact on the market
3.6.Government regulations
3.6.1.U.S. FDA
3.6.2.European Conformity (CE) mark
3.6.3.Ministry of Health, Labor, and Welfare (MHLW)
3.7.Reimbursement scenarios
3.8.Clinical trials
3.9.Patent analysis
3.9.1.Patents Registered/Approved, 2011-2020
3.9.2.Patents Registered/Approved, by Applicants, 2011-2020
3.9.3.U.S. patent analysis, by market applicants
3.9.4.PCT patent analysis, by market applicants
3.9.5.Europe patent analysis, by market applicants
3.9.6.China patent analysis, by market applicants
3.9.7.Australia patent analysis by market applicants
3.10.Market Dynamics
3.10.1.Drivers
3.10.1.1.Rise in prevalence of lifestyle diseases
3.10.1.2.Increase in geriatric population
3.10.1.3.Rise in the adoption of remote patient monitoring devices
3.10.2.Restraints
3.10.2.1.Government regulations and reimbursement issues
3.10.2.2.Limited awareness and high costs
3.10.3.Opportunities
3.10.3.1.Untapped markets in developing countries
3.10.3.2.Technological advancements

CHAPTER 4:PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Hemodynamic monitoring devices
4.2.1.Key market trends and opportunity
4.2.2.Market size and forecast
4.2.3.Market share analysis, by country
4.2.4.Blood glucose monitors
4.2.4.1.Market size and forecast
4.2.5.Blood gas and electrolyte analyzers/monitors
4.2.5.1.Market size and forecast
4.2.6.Blood pressure monitors
4.2.6.1.Market size and forecast
4.3.Neuromonitoring devices
4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast
4.3.3.Market share analysis, by country
4.3.4.Electroencephalograph (EEG) devices
4.3.4.1.Market size and forecast
4.3.5.Transcranial dopplers (TCD)
4.3.5.1.Market size and forecast
4.3.6.Magnetoencephalograph (MEG) devices
4.3.6.1.Market size and forecast
4.3.7.Intracranial pressure monitors (ICP)
4.3.7.1.Market size and forecast
4.3.8.Cerebral oximeters
4.3.8.1.Market size and forecast
4.4.Cardiac monitoring devices
4.4.1.Key market trends and opportunities
4.4.2.Market size and forecast
4.4.3.Market share analysis, by country
4.4.4.Electrocardiogram (ECG) devices
4.4.4.1.By type
4.4.4.2.By lead type
4.4.4.3.Market size and forecast
4.4.5.Holter monitors
4.4.5.1.Market size and forecast
4.4.6.Event monitors
4.4.6.1.By type
4.4.6.2.By technology
4.4.6.3.Market size and forecast
4.4.7.Others (Implantable loop recorder, Cardiac output monitor and others)
4.4.7.1.Market size and forecast
4.5.Fetal neonatal monitoring devices
4.5.1.Key market trends and opportunities
4.5.2.Market size and forecast
4.5.3.Market share analysis, by country
4.5.4.Ultrasound
4.5.4.1.Market size and forecast
4.5.5.Electronic Fetal Monitoring Devices
4.5.5.1.Market size and forecast
4.5.6.Fetal Doppler Monitoring Devices
4.5.6.1.Market size and forecast
4.5.7.Others
4.5.7.1.Market size and forecast
4.6.Respiratory monitors
4.6.1.Key market trends and opportunities
4.6.2.Market size and forecast
4.6.3.Market share analysis, by country
4.6.4.Capnographs
4.6.4.1.Market size and forecast
4.6.5.Pulse oximeters
4.6.5.1.Market size and forecast
4.6.6.Sleep apnea monitors
4.6.6.1.Market size and forecast
4.6.7.Spirometers
4.6.7.1.Market size and forecast
4.7.Multiparameter monitoring devices
4.7.1.Key market trends and opportunities
4.7.2.Market size and forecast
4.7.3.Market share analysis, by country
4.7.4.High acuity
4.7.4.1.Market size and forecast
4.7.5.Mid acuity
4.7.5.1.Market size and forecast
4.7.6.Low acuity
4.7.6.1.Market size and forecast
4.8.Remote patient monitoring devices
4.8.1.Key market trends and opportunities
4.8.2.Market size and forecast
4.8.3.Market share analysis, by country
4.9.Weight monitoring devices
4.9.1.Key market trends and opportunities
4.9.2.Market size and forecast
4.9.3.Market share analysis, by country
4.10.Temperature monitoring devices
4.10.1.Key market trends and opportunities
4.10.2.Market size and forecast
4.10.3.Market share analysis, by country
4.11.Urine output monitoring
4.11.1.Key market trends and opportunities
4.11.2.Market size and forecast
4.11.3.Market share analysis, by country

CHAPTER 5:PATIENT MONITORING DEVICES MARKET, BY END USER
5.1.Overview
5.1.1.Market size and forecast
5.2.Hospitals
5.2.1.Market size and forecast
5.2.2.Market share analysis, by country
5.3.Home settings
5.3.1.Market size and forecast
5.3.2.Market share analysis, by country
5.4.Ambulatory surgical centers (ASCs)
5.4.1.Market size and forecast
5.4.2.Market share analysis, by country

CHAPTER 6:PATIENT MONITORING DEVICES MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key opportunities and forecast
6.2.2.Market size and forecast
6.2.2.1.U.S. market size and forecast
6.2.2.2.Canada market size and forecast
6.2.2.3.Mexico market size and forecast
6.3.Europe
6.3.1.Key opportunities and forecast
6.3.2.Market size and forecast
6.3.2.1.Germany market size and forecast
6.3.2.2.France market size and forecast
6.3.2.3.UK market size and forecast
6.3.2.4.Italy market size and forecast
6.3.2.5.Spain market size and forecast
6.3.2.6.Rest of Europe market size and forecast
6.4.Asia-Pacific
6.4.1.Key opportunities and forecast
6.4.2.Market size and forecast
6.4.2.1.Japan market size and forecast
6.4.2.2.China market size and forecast
6.4.2.3.Australia market size and forecast
6.4.2.4.India market size and forecast
6.4.2.5.South Korea market size and forecast
6.4.2.6.Rest of Asia-Pacific market size and forecast
6.5.LAMEA
6.5.1.Key opportunities and forecast
6.5.2.Market size and forecast
6.5.2.1.Brazil market size and forecast
6.5.2.2.Turkey market size and forecast
6.5.2.3.Venezuela market size and forecast
6.5.2.4.Saudi Arabia market size and forecast
6.5.2.5.Rest of LAMEA market size and forecast

CHAPTER 7:COMPANY PROFILES
7.1.ABBOTT LABORATORIES
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments
7.2.BIOTRONIK SE & CO. KG
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Key strategic moves and developments
7.3.GENERAL ELECTRIC COMPANY (GE HEALTHCARE)
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments
7.4.F. HOFFMANN-LA ROCHE LTD.
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.4.6.Key strategic moves and developments
7.5.JOHNSON & JOHNSON
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments
7.6.KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.6.6.Key strategic moves and developments
7.7.MASIMO CORPORATION
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Product portfolio
7.7.4.Business performance
7.7.5.Key Strategic Moves and Developments
7.8.MEDTRONIC PLC.
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Medtronic offers following patient monitoring devices
7.8.5.Business performance
7.8.6.Key strategic moves and developments
7.9.NIHON KOHDEN CORPORATION
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance
7.9.6.Key strategic moves and developments
7.10.OMRON CORPORATION
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance
7.10.6.Key Strategic Moves and Development

List of Tables

TABLE 01.CLINICAL TRIALS: PATIENT MONITORING DEVICES MARKET, 2013-2020
TABLE 02.PATENTS REGISTERED/APPROVED ACROSS THE GLOBE, 2011-2020
TABLE 03.PATENTS REGISTERED/APPROVED, BY APPLICANTS, 2011-2020
TABLE 04.U.S. PATENT ANALYSIS, BY MARKET APPLICANTS, 2011- 2020
TABLE 05.PCT PATENT ANALYSIS, BY APPLICANTS, 2011-2020
TABLE 06.EUROPE PATENT ANALYSIS, BY MARKET APPLICANTS, 2011-2020
TABLE 07.CHINA PATENT ANALYSIS, BY MARKET APPLICANTS, 2011-2020
TABLE 08.AUSTRALIA PATENT ANALYSIS, BY MARKET APPLICANTS, 2011-2020
TABLE 09.GLOBAL PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 10.HEMODYNAMIC MONITORING DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
TABLE 11.HEMODYNAMIC MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 12.BLOOD GLUCOSE MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 13.BLOOD GAS & ELECTROLYTE ANALYSERS MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 14.BLOOD PRESSURE MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 15.NEUROMONITORING DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
TABLE 16.NEUROMONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 17.ELECTROENCEPHALOGRAPH MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 18.TRANSCRANIAL DOPPLERS MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 19.MAGNETOENCEPHALOGRAPH MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 20.INTRACRANIAL PRESSURE MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 21.CEREBRAL OXIMETER MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 22.CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
TABLE 23.CARDIAC MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 24.ELECTROCARDIOGRAM MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 25.HOLTER MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 26.EVENT MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 27.OTHER CARDIAC MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 28.FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
TABLE 29.FETAL AND NEONATAL MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 30.ULTRASOUND MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 31.ELECTRONIC FETAL MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 32.FETAL DOPPLER MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 33.OTHER FETAL AND NEONATAL MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 34.RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
TABLE 35.RESPIRATORY MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 36.CAPNOGRAPH MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 37.PULSE OXIMETER MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 38.SLEEP APNEA MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 39.SPIROMETER MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 40.MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
TABLE 41.MULTIPARAMETER MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 42.HIGH ACUITY MULTIPARAMETER MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 43.MID ACUITY MULTIPARAMETER MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 44.LOW ACUITY MULTIPARAMETER MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 45.REMOTE PATIENT MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 46.WEIGHT MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 47.TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 48.PATIENT MONITORING DEVICES MARKET FOR URINE MONITORING DEVICES, BY REGION, 2019-2027 ($MILLION)
TABLE 49.GLOBAL PATIENT MONITORING DEVICES MARKET, BY END USER 2019-2027 ($MILLION)
TABLE 50.PATIENT MONITORING DEVICES MARKET IN HOSPITALS, BY REGION, 2019-2027 ($MILLION)
TABLE 51.PATIENT MONITORING DEVICES MARKET IN HOME SETTING, BY REGION, 2019-2027 ($MILLION)
TABLE 52.PATIENT MONITORING DEVICES MARKET IN AMBULATORY SURGICAL CENTERS, BY REGION, 2019-2027 ($MILLION)
TABLE 53.PATIENT MONITORING DEVICES MARKET, BY REGION, 2019-2027($MILLION)
TABLE 54.NORTH AMERICA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
TABLE 55.NORTH AMERICA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
TABLE 56.NORTH AMERICA PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019-2027($MILLION)
TABLE 57.U.S. PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
TABLE 58.U.S. PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
TABLE 59.CANADA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
TABLE 60.CANADA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
TABLE 61.MEXICO PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
TABLE 62.MEXICO PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
TABLE 63.EUROPE PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
TABLE 64.EUROPE PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
TABLE 65.EUROPE PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019-2027($MILLION)
TABLE 66.GERMANY PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
TABLE 67.GERMANY PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
TABLE 68.FRANCE PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
TABLE 69.FRANCE PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
TABLE 70.UK PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
TABLE 71.UK PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
TABLE 72.ITALY PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
TABLE 73.ITALY PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
TABLE 74.SPAIN PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
TABLE 75.SPAIN PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
TABLE 76.REST OF EUROPE PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
TABLE 77.REST OF EUROPE PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
TABLE 78.ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
TABLE 79.ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
TABLE 80.ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019-2027($MILLION)
TABLE 81.JAPAN PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
TABLE 82.JAPAN PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
TABLE 83.CHINA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
TABLE 84.CHINA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
TABLE 85.AUSTRALIA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
TABLE 86.AUSTRALIA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
TABLE 87.INDIA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
TABLE 88.INDIA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
TABLE 89.SOUTH KOREA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
TABLE 90.SOUTH KOREA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
TABLE 91.REST OF ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
TABLE 92.REST OF ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
TABLE 93.LAMEA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
TABLE 94.LAMEA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
TABLE 95.LAMEA PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019-2027($MILLION)
TABLE 96.BRAZIL PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
TABLE 97.BRAZIL PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
TABLE 98.TURKEY PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
TABLE 99.TURKEY PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
TABLE 100.VENEZUELA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
TABLE 101.VENEZUELA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
TABLE 102.SAUDI ARABIA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
TABLE 103.SAUDI ARABIA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
TABLE 104.REST OF LAMEA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
TABLE 105.REST OF LAMEA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
TABLE 106.ABBOTT: COMPANY SNAPSHOT
TABLE 107.ABBOTT: OERATING SEGMENT
TABLE 108.ABBOTT: PRODUCT PORTFOLIO
TABLE 109.BIOTRONIK: COMPANY SNAPSHOT
TABLE 110.BIOTRONIK: OPERATING SEGMENTS
TABLE 111.BIOTRONIK: PRODUCT PORTFOLIO
TABLE 112.GE: COMPANY SNAPSHOT
TABLE 113.GE: OPERATING SEGMENTS
TABLE 114.GE: PRODUCT PORTFOLIO
TABLE 115.ROCHE: COMPANY SNAPSHOT
TABLE 116.ROCHE: OERATING SEGMENT
TABLE 117.ROCHE: PRODUCT PORTFOLIO
TABLE 118.J&J: COMPANY SNAPSHOT
TABLE 119.J&J: OPERATING SEGMENTS
TABLE 120.J&J: PRODUCT PORTFOLIO
TABLE 121.PHILIPS: COMPANY SNAPSHOT
TABLE 122.PHILIPS: OPERATING SEGMENTS
TABLE 123.PHILIPS: PRODUCT PORTFOLIO
TABLE 124.MASIMO: COMPANY SNAPSHOT
TABLE 125.MASIMO: PRODUCT PORTFOLIO
TABLE 126.MEDTRONIC: COMPANY SNAPSHOT
TABLE 127.MEDTRONIC: OPERATING BUSINESS SEGMENTS
TABLE 128.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 129.NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
TABLE 130.GSK: PRODUCT PORTFOLIO
TABLE 131.OMRON CORPORATION: COMPANY SNAPSHOT
TABLE 132.OMRON CORPORATION: OPERATING SEGMENTS
TABLE 133.OMRON CORPORATION: PRODUCT PORTFOLIO

List of Figures

FIGURE 01.TOP INVESTMENT POCKETS: GLOBAL PATIENT MONITORING DEVICES MARKET, BY DEVICE TYPE
FIGURE 02.TOP WINNING STRATEGIES, BY YEAR, 2017-2020*
FIGURE 03.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017-2020* (%)
FIGURE 04.TOP WINNING STRATEGIES, BY COMPANY, 2017-2020* (%)
FIGURE 05.TOP PLAYER POSITIONING
FIGURE 06.MODERATE BARGAINING POWER OF BUYERS
FIGURE 07.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 08.HIGH THREAT OF NEW ENTRANTS
FIGURE 09.MODERATE THREAT OF SUBSTITUTION
FIGURE 10.HIGH COMPETITIVE RIVALRY
FIGURE 11.PATENTS REGISTERED/APPROVED, 2011-2020
FIGURE 12.PATENTS REGISTERED/APPROVED, BY APPLICANTS, 2011-2020
FIGURE 13.U.S. PATENT ANALYSIS, BY MARKET APPLICANTS, 2011-2020
FIGURE 14.PCT PATENT ANALYSIS, BY MARKET APPLICANTS, 2011-2020
FIGURE 15.EUROPE PATENT ANALYSIS, BY MARKET APPLICANTS, 2011-2020
FIGURE 16.CHINA PATENT ANALYSIS, BY MARKET APPLICANTS, 2011-2020
FIGURE 17.AUSTRALIA PATENT ANALYSIS BY MARKET APPLICANTS, 2011-2020
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF HEMODYNAMIC PATIENT MONTORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF NEUROMONITORING PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF CARDIAC PATIENT MONTORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF FETAL AND NEONATAL MONITORING PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF RESPIRATORY PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF MULTIPARAMETER PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF REMOTE PATEINT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF WEIGHT PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 26.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF TEMPERATURE PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 27.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF URINE OUTPUT PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 28.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF HOSPITAL PATIENT MONTORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 29.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF HOME SETTINGS PATIENT MONTORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 30.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF AMBULATORY SURGICAL CENTERS PATIENT MONTORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 31.ABBOTT: NET SALES, 2017-2019 ($MILLION)
FIGURE 32.ABBOTT: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 33.ABBOTT: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 34.GE: NET SALES, 2017-2019 ($MILLION)
FIGURE 35.GE: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 36.GE: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 37.ROCHE: NET SALES, 2017-2019 ($MILLION)
FIGURE 38.ROCHE: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 39.ROCHE: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 40.J&J: NET SALES, 2017-2019 ($MILLION)
FIGURE 41.J&J: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 42.J&J: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 43.PHILIPS: NET SALES, 2017-2019 ($MILLION)
FIGURE 44.PHILIPS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 45.PHILIPS: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 46.MASIMO: NET SALES, 2017-2019 ($MILLION)
FIGURE 47.MASIMO: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 48.MEDTRONIC: NET SALES, 2017-2019 ($MILLION)
FIGURE 49.MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 50.MEDTRONIC: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 51.NIHON KOHDEN: NET SALES, 2016-2018 ($MILLION)
FIGURE 52.NIHON KOHDEN: REVENUE SHARE, BY PRODUCT SEGMENT, 2018 (%)
FIGURE 53.NIHON KOHDEN: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 54.OMRON CORPORATION: NET SALES, 2016-2018 ($MILLION)
FIGURE 55.OMRON CORPORATION: REVENUE SHARE, BY SEGMENT, 2018 (%)
FIGURE 56.OMRON CORPORATION: REVENUE SHARE, BY REGION, 2018 (%)

Companies Mentioned
These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Medtronic, Inc., Biotronik, F. Hoffmann-La Roche Ltd., GE Healthcare Ltd, Masimo Corporation, Nihon Kohden Corporation, Johnson and Johnson, Omron Healthcare Co. Ltd., Abbott Laboratories, and Koninklijke Philips N.V.